Search

everythinglearnresearchcommunity

for

Search:↓

Combination therapy with fesoterodine and doxazosin improves bladder function and delays BPH progression.

The composition helps treat hair loss.

New compounds show promise as nonsteroidal treatments for hair loss.

Combination therapy improves urinary flow and reduces residual urine, but needs better stent design.

Using 5-alpha reductase inhibitors may lower the risk of opioid addiction in men taking opioids.

Taking both finasteride and dutasteride for prostate issues may raise the risk of heart problems.

Finasteride modifies 5-alpha-reductases through a two-step process, affecting inhibitor potency and possibly causing side effects.

Certain compounds reduced hamster flank organ size by inhibiting 5α-reductase, like finasteride, without affecting androgen receptors.

5-alpha-reductase inhibitors can lower prostate cancer risk but may increase high-grade tumors and cause sexual side effects.

Dalpiciclib is the safest and most satisfying CDK4/6 inhibitor for advanced breast cancer patients in China.

Mimicking the steroid A-ring may help create effective enzyme inhibitors for prostate disease treatment.

New compounds were made that effectively block enzymes related to prostate issues and hair loss.

Finasteride helps reduce pain and inflammation in animals.

Compounds 4, 4b, and 4c effectively inhibit an enzyme linked to testosterone conversion without significant toxicity.

Finasteride blocks progesterone's effect on brain activity linked to epilepsy.

Scientists found new, better-working inhibitors for a hormone-related enzyme.

Dutasteride more effectively lowers DHT levels in men with enlarged prostates than finasteride.

Dual therapy with specific medications can help manage male urinary symptoms and reduce side effects.

Knowing about potential side effects can make them more likely to happen.

5-alpha reductase inhibitors, like finasteride and dutasteride, are used for prostate issues, hair loss, and excessive hair growth, may help with COVID-19, but can cause sexual and mental health side effects, and their use in preventing prostate cancer needs more examination.

LGF injections may improve early Peyronie's disease by reducing penile curvature and plaque size.

Finasteride effectively and safely treats recurrent priapism in children and adolescents with sickle cell disease.

5-alpha reductase inhibitors may cause sexual side effects, breast complications, and other health risks in men with hair loss.

Dutasteride effectively treats benign prostatic hyperplasia and may reduce prostate cancer risk.

The method effectively measures drug impact on DHT levels in prostate treatments.

More men are using medication for benign prostatic hyperplasia, influenced by marketing and FDA approvals.

New pyrazole-based inhibitors show promise for treating metabolic diseases and other conditions.